Kaye Scholer Company Profile

21:21 EST 16th December 2018 | BioPortfolio



425 Park Avenue
New York
New York
United States of America


Phone: (212) 836-8000
Fax: (212) 836-8689

News Articles [6 Associated News Articles listed on BioPortfolio]

Click Therapeutics Adds Randall Kaye, Austin Speier to C-Suite

Click Therapeutics has appointed Randall Kaye to serve as its chief medical officer. Kaye comes to Click from SSI Strategy, where he was chief scientific officer. New York-based Click also appointed A...

With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO

Ed Kaye stepped aside from Sarepta Therapeutics (NASDAQ: SRPT) last year after leading the company through one of the most noteworthy and controversial drug approvals in recent memory, for the Duchenn...

"Canadians have given up on Israeli cannabis exports"

DLA Piper Canada partner Adv. Noam Goodman and iCan founder Saul Kaye speak to "Globes" about the cannabis opportunities Israel is missing.

Click Therapeutics Expands Executive Team with Chief Medical Officer and Chief Strategy Officer

- Dr. Randall Kaye and Austin Speier Join Executive Team - Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical...

Stoke Therapeutics Appoints Biotech Veteran Arthur Tzianabos, Ph.D. to Board of Directors

Stoke Therapeutics, Inc., today announced that veteran biotech executive Arthur Tzianabos, Ph.D., who has extensive experience in the development and commercialization of r...

Kennedy Krieger Institute to Honor Judy Woodruff During DC Benefit to Support Pediatric Brain Research

On Wednesday, October 10, Kennedy Krieger Institute will salute pioneering news anchor Judy Woodruff, whose experience supporting her eldest son after a traumatic brain injury ins...

Drugs and Medications [0 Results]


PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Damus-Kaye-Stansel: Valuable option for retraining of Left ventricle in late arterial switch for Transposition of great arteries.

Here, we report a case of 3 year girl with d-TGA with IVS managed by Damus-Kaye-Stansel with right bidirectional. cavopulmonary anastomosis in first stage to train LV followed by definitive surgery (a...

Damus-Kaye-Stansel procedure avoids coronary obstruction in complex D-transposition.

Although all coronary anatomy in D-transposition of the great arteries may be "switchable," there are reports in the literature of early and late coronary obstruction following the arterial switch ope...

The Damus-Kaye-Stansel 0peration: Management of systemic ventricular outflow tract obstruction.

The Damus-Kaye-Stansel (DKS) anastomosis was originally described for the treatment of transposition of the great arteries but it is now used mainly for the treatment of single ventricle anomalies in ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Cardiac Biomarkers in Patients With Single Ventricle Physiology

All neonates with congenital heart disease undergoing stage one palliation (Norwood procedure, Damus-Kaye-Stansel procedure) at Texas Children's Hospital will be regularly monitored for B-...

Companies [5 Associated Companies listed on BioPortfolio]

Kaye Scholer LLP

Kaye Scholer


Kaye/Bassman International Corp.

Company History | Welcome to Kaye/Bassman International Corp. (KBIC). Our organization was founded in 1981 with a mission of positively impacting companies and enhancing careers by providing the fines...

Partnership Fund for New York City

The Partnership Fund for New York City is the $115 million investment arm of the Partnership for New York City ( The Fund’s mission is to engage the City’...

Osprey Medical Inc.

Osprey Medical's core technologies originated from research conducted by Dr David Kaye at Melbourne’s Baker IDI Heart and Diabetes Institute. Osprey is focused on improving p...

More Information about "Kaye Scholer" on BioPortfolio

We have published hundreds of Kaye Scholer news stories on BioPortfolio along with dozens of Kaye Scholer Clinical Trials and PubMed Articles about Kaye Scholer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kaye Scholer Companies in our database. You can also find out about relevant Kaye Scholer Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record